Loading
Latest filing published 20 Dec 2012 for DUSA PHARMACEUTICALS INC, €181k.
No signal scores available.
Stuart L. Marcus appears in our data through filings on Dusa Pharmaceuticals Inc shares, published by SEC (Form 4). Between 9 May 2008 and 20 December 2012, the trades on record add up to 36 filings.
No open-market purchase appears, only 17 sales worth €86k. Besides market trades, the filings include 15 share grants and 2 option exercises. Since January 2012: no purchases and 17 sales on the market.
On 20 December 2012 came the latest disclosure, a transaction for €504k in Dusa Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 36 declarations